After FDA Approval, Allergan Ready To Sell Drug For Eyelashes : FullHealth.net

Sunday - December 28, 2008 Home \| Login \| Privacy Policy \| About the Site \| Site Help \| Site Map \| Contact Us

Topics in Health News

		• (Update) Many Unhappy With New Nursing Home Ranking System
• After FDA Approval, Allergan Ready To Sell Drug For Eyelashes
• Ask the doctor: How do I stop the ringing in my ears?

• Being Just A Little Overweight Increases Heart Risks
• Cliff Richard: How I stayed healthy over 50 years of showbiz
• Common Medical Myths Debunked
• Common Strain Of Flu In The U.S. Is Resistant To Tamiflu
• Despite Flaws, Colonoscopy Screenings Still Save Lives
• Diabetes drugs raise womens risk of broken bones say doctors
• Doctors warned Eddy Shah his high living would trigger diabetes. But foolishly, he ignored them...

• Drug Protects Mice Exposed To Smoking From Lung Disease
• FDA Issues Warning For Dangerous Weight Loss Drugs
• FDA Slams Coca-Cola For Diet Coke Plus, Urges New Label
• First U.S. face-transplant performed in Ohio
• Five Tips To Help You Eat Healthy During Christmas Holiday
• Five Tips To Help You Eat Healthy During Christmas Holiday
• Grumpy NHS nurses encouraged to Carry On laughing with humour workshop
• Handful of nuts a day can help prevent onset of heart disease

• How living with the mother-in-law can damage a womans health
• I went abroad for a hip op - now every step is agony
• Jane Clarke: The hidden dangers in a tempting festive tipple

• Medical ghostwriters paid to write favorable drug reports
• New Ratings Reveal Non-Profit Nursing Homes Are Best
• New study shows supplements dont lower risk of prostate cancer
• Now even sugar overload can lead to addiction, scientists warn
• Osteopenia among Yemeni Women
• Push Is On To Ban Smoking In More Public Across Pennsylvania
• Readers’ Thoughts On The Debated Right Of Conscience Rule
• Red Cross Needs Some Christmas Magic, More Blood Donors
• Rise in children with allergies blamed on parents hysteria about nuts
• Scientists Able To Create Nerve Disease In Lab For Research
• Scientists Able To Create Nerve Disease In Lab For Research
• Scientists find nutty risk reducer: Eat more nuts
• Seniors In U.S. Taking Hazardous Combinations Of Drugs
• Simple Measures Can Prevent Injuries to Children
• Sleeping Is Beneficial To Your Heart, Prevents Coronary Disease
• State Confirms First Case Of The Flu, 38-Year Old Woman
• State Confirms First Case Of The Flu, 38-Year Old Woman
• Surgeon In U.S. Takes Fat From Patients To Power His Car
• Teenage girls who lack vitamin D risk weight gain and stunted growth
• The DIY test that checks if your vasectomy has worked
• Toy Safety Put Into Focus With Christmas Holiday Nearing
• US FDA Panel Recommends Restrictions on Two Asthma Drugs
• What Are Your Thoughts On New Right Of Conscience Rule?
• Woman Who Saved Friend From Car Crash Can Be Sued
• Young Texas Boy Recovers After Being Decapitated In Car Crash

Health News >

After FDA Approval, Allergan Ready To Sell Drug For Eyelashes

This article has been read 5 times

Boston (dbTechno) - Allergan Inc. is getting ready to sell their glaucoma drug Lumigan for the purpose of enhancing the appearance of your eyelashes.

The U.S. Food and Drug Administration (FDA) has given approval to the glaucoma drug to be used cosmetically.

The drug is going to be marketed under the brand name of Latisse.

The drug will be used to treat a condition known as hypotrichosis.Â This occurs in people who have a hard time growing eyelashes.

The idea behind the drug, once launched, is to help build up longer, thicker eyelahes in people.

The FDA approval is for the drug to be taken once each day, and is expected to be released in Q1.

This is a prescription drug, and was found to be highly successful in trials conducted.

An FDA panel recently gave a unanimous approval to approving the drug for this use.

New Topics in FullHealth.net

After FDA Approval, Allergan Ready To Sell Drug For Eyelashes

Sleeping Is Beneficial To Your Heart, Prevents Coronary Disease

Seniors In U.S. Taking Hazardous Combinations Of Drugs

FDA Slams Coca-Cola For Diet Coke Plus, Urges New Label

Surgeon In U.S. Takes Fat From Patients To Power His Car

Want to Stay Warm in the Winter? Think COLD

Simple Measures Can Prevent Injuries to Children

Osteopenia among Yemeni Women

FDA Issues Warning For Dangerous Weight Loss Drugs

Drug Protects Mice Exposed To Smoking From Lung Disease

©2008-2009 FullHealth.net All rights reserved.
FullHealth.net does not provide medical advice, diagnosis or treatment. See additional information below.
The contents of the FullHealth.net Site, such as text, graphics, images, and other material contained on the FullHealth.net Site ("Content") are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on the FullHealth.net Site!
If you think you may have a medical emergency, call your doctor or 911 immediately. FullHealth.net does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Site. Reliance on any information provided by FullHealth.net, FullHealth.net employees, others appearing on the Site at the invitation of FullHealth.net, or other visitors to the Site is solely at your own risk.
The Site may contain health- or medical-related materials that are sexually explicit. If you find these materials offensive, you may not want to use our Site. The Site and the Content are provided on an "as is" basis.